Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Just the Facts, Ma'am: A Compendium of Liberal Fiction -- Ignore unavailable to you. Want to Upgrade?

To: Sully- who wrote (77253)	2/4/2010 2:21:26 AM
From: Sully-	Respond to of 90947

Andrew Sullivan hits new low in attacking Palin By: Mark Hemingway Commentary Staff Writer beltway-confidential 02/03/10 2:18 PM EST At what point does Andrew Sullivan's derangement over Sarah Palin and his bizarre conspiracy theories about how her son was really birthed by her daughter become an issue for an otherwise respectable publication such as The Atlantic? If his employers don't take action over this blog post of his, then we're totally through the looking glass: <<< The medical term for Down Syndrome is Trisomy-21 or Trisomy-g. It is often shortened in medical slang to Tri-g. Is it not perfectly possible that the very name given to this poor child, being reared by Bristol, is another form of mockery of his condition, along with the "retarded baby" tag? And does the way in which this poor child was hauled around the country on a book tour, being dragged out in front of flash photographs in the middle of the night, barely clothed, suggest someone who actually cares for children with special needs, or rather sees them as a way to keep the spotlight on her? C'mon, Levi. Write that book. Expose this fraud. >>> Yes, Sarah Pailn clearly meant to mock her child's disability with his name. In other news, Sullivan's recreational habits are clearly interfering with his job. He's become the Gilbert Arenas of political journalism. washingtonexaminer.com